• Something wrong with this record ?

Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives

JE. Gutiérrez, H. Ramírez, E. Fernandez-Moreira, ME. Acosta, MR. Mijares, JB. De Sanctis, S. Gurská, P. Džubák, M. Hajdúch, L. Labrador-Fagúndez, BG. Stella, LJ. Díaz-Pérez, G. Benaim, JE. Charris

. 2023 ; 16 (12) : . [pub] 20231209

Status not-indexed Language English Country Switzerland

Document type Journal Article

Grant support
028/2022, 055/2023 The project was partially funded by Ministero del Poder Popular para Ciencias y Tecnología
2022-MED-001 Escuela de Medicina, Universidad de Especialidades Espíritu Santo (UEES)

A series of heterocyclic chloroquine hybrids, containing a chain of two carbon atoms at position four of the quinolinic chain and acting as a link between quinoline and several benzoyl groups, is synthesized and screened in vitro as an inhibitor of β-hematin formation and in vivo for its antimalarial activity against chloroquine-sensitive strains of Plasmodium berghei ANKA in this study. The compounds significantly reduced haeme crystallization, with IC50 values < 10 μM. The values were comparable to chloroquine's, with an IC50 of 1.50 ± 0.01 μM. The compounds 4c and 4e prolonged the average survival time of the infected mice to 16.7 ± 2.16 and 14.4 ± 1.20 days, respectively. We also studied the effect of the compounds 4b, 4c, and 4e on another important human parasite, Leishmania mexicana, which is responsible for cutaneous leishmaniasis, demonstrating a potential leishmanicidal effect against promasigotes, with an IC50 < 10 μM. Concerning the possible mechanism of action of these compounds on Lesihmania mexicana, we performed experiments demonstrating that these three compounds could induce the collapse of the parasite mitochondrial electrochemical membrane potential (Δφ). The in vitro cytotoxicity assays against mammalian cancerous and noncancerous human cell lines showed that the studied compounds exhibit low cytotoxic effects. The ADME/Tox analysis predicted moderate lipophilicity values, low unbound fraction values, and a poor distribution for these compounds. Therefore, moderate bioavailability was expected. We calculated other molecular descriptors, such as the topological polar surface area, according to Veber's rules, and except for 2 and 4i, the rest of the compounds violated this descriptor, demonstrating the low antimalarial activity of our compounds in vivo.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23022335
003      
CZ-PrNML
005      
20240116163015.0
007      
ta
008      
240105s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ph16121709 $2 doi
035    __
$a (PubMed)38139835
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Gutiérrez, Joyce E $u Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, Venezuela
245    10
$a Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives / $c JE. Gutiérrez, H. Ramírez, E. Fernandez-Moreira, ME. Acosta, MR. Mijares, JB. De Sanctis, S. Gurská, P. Džubák, M. Hajdúch, L. Labrador-Fagúndez, BG. Stella, LJ. Díaz-Pérez, G. Benaim, JE. Charris
520    9_
$a A series of heterocyclic chloroquine hybrids, containing a chain of two carbon atoms at position four of the quinolinic chain and acting as a link between quinoline and several benzoyl groups, is synthesized and screened in vitro as an inhibitor of β-hematin formation and in vivo for its antimalarial activity against chloroquine-sensitive strains of Plasmodium berghei ANKA in this study. The compounds significantly reduced haeme crystallization, with IC50 values < 10 μM. The values were comparable to chloroquine's, with an IC50 of 1.50 ± 0.01 μM. The compounds 4c and 4e prolonged the average survival time of the infected mice to 16.7 ± 2.16 and 14.4 ± 1.20 days, respectively. We also studied the effect of the compounds 4b, 4c, and 4e on another important human parasite, Leishmania mexicana, which is responsible for cutaneous leishmaniasis, demonstrating a potential leishmanicidal effect against promasigotes, with an IC50 < 10 μM. Concerning the possible mechanism of action of these compounds on Lesihmania mexicana, we performed experiments demonstrating that these three compounds could induce the collapse of the parasite mitochondrial electrochemical membrane potential (Δφ). The in vitro cytotoxicity assays against mammalian cancerous and noncancerous human cell lines showed that the studied compounds exhibit low cytotoxic effects. The ADME/Tox analysis predicted moderate lipophilicity values, low unbound fraction values, and a poor distribution for these compounds. Therefore, moderate bioavailability was expected. We calculated other molecular descriptors, such as the topological polar surface area, according to Veber's rules, and except for 2 and 4i, the rest of the compounds violated this descriptor, demonstrating the low antimalarial activity of our compounds in vivo.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ramírez, Hegira $u Facultad de Ciencias de la Salud y Desarrollo Humano, Univesidad Ecotec, Km. 13.5 Samborondón, Guayas, Guayaquil 092302, Ecuador $1 https://orcid.org/0000000319166118
700    1_
$a Fernandez-Moreira, Esteban $u Escuela de Medicina, Universidad Espíritu Santo, Samborondón, Guayas, Guayaquil 092301, Ecuador
700    1_
$a Acosta, María E $u Unidad de Bioquímica, Facultad de Farmacia, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, Venezuela
700    1_
$a Mijares, Michael R $u Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, Venezuela $1 https://orcid.org/0000000200552804
700    1_
$a De Sanctis, Juan Bautista $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000254804608
700    1_
$a Gurská, Soňa $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech Republic
700    1_
$a Džubák, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000230985969 $7 xx0080445
700    1_
$a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech Republic $1 https://orcid.org/000000024834908X $7 xx0050218
700    1_
$a Labrador-Fagúndez, Liesangerli $u Unidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, Venezuela $1 https://orcid.org/0009000422352469
700    1_
$a Stella, Bruno G $u Unidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, Venezuela $1 https://orcid.org/0009000189864694
700    1_
$a Díaz-Pérez, Luis José $u Unidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, Venezuela $1 https://orcid.org/0000000291977815
700    1_
$a Benaim, Gustavo $u Unidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, Venezuela $u Instituto de Biología Experimental, Facultad de Ciencias, Central University of Venezuela, Caracas 1040, Venezuela $1 https://orcid.org/0000000293595546
700    1_
$a Charris, Jaime E $u Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, Venezuela $1 https://orcid.org/0000000344042619
773    0_
$w MED00184066 $t Pharmaceuticals (Basel, Switzerland) $x 1424-8247 $g Roč. 16, č. 12 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38139835 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240105 $b ABA008
991    __
$a 20240116163012 $b ABA008
999    __
$a ok $b bmc $g 2036244 $s 1208780
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 16 $c 12 $e 20231209 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
GRA    __
$a 028/2022, 055/2023 $p The project was partially funded by Ministero del Poder Popular para Ciencias y Tecnología
GRA    __
$a 2022-MED-001 $p Escuela de Medicina, Universidad de Especialidades Espíritu Santo (UEES)
LZP    __
$a Pubmed-20240105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...